"button" data-redirect-url=" data-display-label="0" data-show-count="1" data-bookmark-label="Save" ...

The research builds on previous findings connecting red and processed meats with Type 2 diabetes. By Alice Callahan For sausage, salami and steak lovers, the news has not been good. Scientists have ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s FARXIGA ® (dapagliflozin) has been approved by the US Food and Drug Administration (FDA) to improve glycemic control in pediatric patients with type-2 ...

Astrazeneca Korea Co. Ltd. will pull its blockbuster diabetes drug, Forxiga (dapagliflozin), from the South Korean market, a company official confirmed to BioWorld, citing “multiple factors” like ...

Leo, a 22-year-old man who received a diagnosis of type 1 diabetes at 17 years of age, has struggled to meet glucose targets. As a young adult, he has many competing priorities, and diabetes is not ...

Treatment with the diabetes and weight loss drug semaglutide may allow people newly diagnosed with Type 1 diabetes to dramatically cut back or even completely stop insulin injections, a very small ...

Paper craft illustration of human chest with heart and pacemaker. The human heart beats roughly 3 billion times during the course of an average lifetime. Every single time it beats, blood is drawn ...

The European Commission (EC) has expanded the indication for dapagliflozin (Forxiga) to include heart failure (HF) across the full spectrum of left ventricular ejection fraction — including HF with ...

AstraZeneca’s SGLT2 diabetes drug Forxiga has another approval to celebrate. The drug, known as Farxiga in the U.S., gained a nod in Europe to treat patients suffering from heart failure with any type ...

On January 22, AstraZeneca (AZ) announced the approval of Xigduo (dapagliflozin and metformin hydrochloride) for the treatment of type 2 diabetes in Europe. The drug is a combination of the SGLT-2 ...